We are focused on the investigation and advancement of diabetes therapies.  Our current research is dedicated to addressing type 1 diabetes.


Cells are the ultimate smart machines delivering therapeutics when needed.

Our proprietary technology will be loaded glucose responsive insulin secreting cells, and implanted under the skin. Once inside the device cells will be protected from the immune system but still able to maintain nutrient exchange to respond to their environment.